Compare Edwards Lifesciences Corporation Common Stock (EW) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Payoneer Global Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Payoneer Global Inc trades at $7.19 (market cap $2.43B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 20.3× Payoneer Global Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | PAYO | |
|---|---|---|
Market Cap | $49.44B | $2.43B |
Volume | 3,508,027 | 1,601,413 |
Sector | Health | Technology |
52-Week High | $95.18 | $7.18 |
52-Week Low | $72.65 | $4.27 |
Enterprise Value | $45.90B | $2.17B |
Typical Hold Time | — | 61 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Payoneer Global (PAYO) trades at $7.16, up 0.14% with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating Q1 2026 estimates but missing Q2 2026. Revenue grew to $821M in 2025, though net income margin compressed to 5.83%. Recent news highlights Payoneer's renewed partnership with Etsy through 2029 and a pending acquisition by Nuvei announced in June 2026.
The outlook is clouded by earnings volatility and acquisition uncertainty, but analyst sentiment remains positive with 60% buy ratings. Key risks include integration challenges post-acquisition and competitive pressures in fintech. The stock's elevated P/E of 51.14 suggests growth expectations must materialize to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
